Is PeterLabs Holdings Berhad (KLSE:PLABS) Using Too Much Debt?
Dec 20
Have your own idea? Try our Stock Screener
Malaysian (KLSE) Pharma Industry Analysis
UpdatedDec 21, 2024
DataAggregated Company Financials
Companies6
- 7D-2.1%
- 3M-4.8%
- 1Y-2.5%
- YTD-2.5%
Over the last 7 days, the Pharma industry has dropped 2.1%, driven by a pullback from Apex Healthcare Berhad of 2.8%. In contrast, PeterLabs Holdings Berhad has gained 11%. Over the last year, the industry has been flat overall. As for the next few years, earnings are expected to grow by 16% per annum.
Industry Valuation and Performance
Has the Malaysian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 21 Dec 2024 | RM 4.1b | RM 2.7b | RM 223.9m | 17.5x | 18.5x | 1.5x |
| Mon, 18 Nov 2024 | RM 4.2b | RM 2.7b | RM 236.8m | 14.2x | 17.7x | 1.5x |
| Wed, 16 Oct 2024 | RM 4.4b | RM 2.7b | RM 230.0m | 14.4x | 19.3x | 1.6x |
| Fri, 13 Sep 2024 | RM 4.2b | RM 2.7b | RM 230.0m | 14.4x | 18.4x | 1.6x |
| Sun, 11 Aug 2024 | RM 4.3b | RM 2.6b | RM 541.3m | 12.5x | 7.9x | 1.6x |
| Tue, 09 Jul 2024 | RM 4.5b | RM 2.6b | RM 541.3m | 13.1x | 8.3x | 1.7x |
| Thu, 06 Jun 2024 | RM 4.5b | RM 2.6b | RM 541.3m | 13.3x | 8.4x | 1.7x |
| Sat, 04 May 2024 | RM 4.8b | RM 2.6b | RM 559.3m | 12.4x | 8.6x | 1.8x |
| Mon, 01 Apr 2024 | RM 4.5b | RM 2.6b | RM 559.3m | 12.4x | 8.1x | 1.7x |
| Wed, 28 Feb 2024 | RM 4.5b | RM 2.6b | RM 557.0m | 12.5x | 8.1x | 1.7x |
| Fri, 26 Jan 2024 | RM 4.3b | RM 2.6b | RM 584.9m | 12.3x | 7.4x | 1.7x |
| Sun, 24 Dec 2023 | RM 4.2b | RM 2.6b | RM 584.9m | 12.4x | 7.3x | 1.7x |
| Tue, 21 Nov 2023 | RM 4.3b | RM 2.6b | RM 596.8m | 12.3x | 7.2x | 1.7x |
| Thu, 19 Oct 2023 | RM 4.3b | RM 2.6b | RM 604.4m | 12.2x | 7.1x | 1.7x |
| Sat, 16 Sep 2023 | RM 4.2b | RM 2.6b | RM 604.4m | 12.3x | 7x | 1.6x |
| Mon, 14 Aug 2023 | RM 4.4b | RM 2.6b | RM 304.7m | 14.1x | 14.4x | 1.7x |
| Wed, 12 Jul 2023 | RM 4.3b | RM 2.6b | RM 304.7m | 14x | 14.1x | 1.7x |
| Fri, 09 Jun 2023 | RM 4.5b | RM 2.6b | RM 304.7m | 14.2x | 14.7x | 1.7x |
| Sun, 07 May 2023 | RM 4.6b | RM 2.5b | RM 289.8m | 13.4x | 16x | 1.9x |
| Tue, 04 Apr 2023 | RM 4.8b | RM 2.5b | RM 289.8m | 13.2x | 16.7x | 1.9x |
| Thu, 02 Mar 2023 | RM 4.8b | RM 2.5b | RM 290.8m | 12.7x | 16.6x | 1.9x |
| Sat, 28 Jan 2023 | RM 4.6b | RM 2.4b | RM 270.7m | 13.4x | 17.1x | 1.9x |
| Mon, 26 Dec 2022 | RM 4.7b | RM 2.4b | RM 270.7m | 13.4x | 17.5x | 1.9x |
| Wed, 23 Nov 2022 | RM 4.2b | RM 2.4b | RM 261.3m | 12.7x | 16.1x | 1.7x |
| Fri, 21 Oct 2022 | RM 4.0b | RM 2.4b | RM 249.0m | 11.6x | 15.9x | 1.7x |
| Sun, 18 Sep 2022 | RM 4.0b | RM 2.4b | RM 249.0m | 11.8x | 16.1x | 1.7x |
| Tue, 16 Aug 2022 | RM 3.9b | RM 2.3b | RM 226.0m | 14.5x | 17.1x | 1.7x |
| Thu, 14 Jul 2022 | RM 3.6b | RM 2.3b | RM 226.0m | 13.5x | 15.7x | 1.5x |
| Sat, 11 Jun 2022 | RM 3.8b | RM 2.3b | RM 226.0m | 14.1x | 16.7x | 1.6x |
| Mon, 09 May 2022 | RM 4.0b | RM 2.2b | RM 204.5m | 16.5x | 19.3x | 1.8x |
| Wed, 06 Apr 2022 | RM 4.0b | RM 2.2b | RM 204.5m | 16.2x | 19.5x | 1.8x |
| Fri, 04 Mar 2022 | RM 3.8b | RM 2.2b | RM 204.5m | 15.9x | 18.7x | 1.7x |
| Sun, 30 Jan 2022 | RM 3.5b | RM 2.1b | RM 187.4m | 15.8x | 18.9x | 1.6x |
| Tue, 28 Dec 2021 | RM 3.7b | RM 2.1b | RM 187.4m | 15.4x | 19.7x | 1.7x |
Price to Earnings Ratio
19.7x
Current Industry PE
- Investors are optimistic on the Malaysian Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 18.5x which is higher than its 3-year average PE of 14.1x.
- The 3-year average PS ratio of 1.7x is higher than the industry's current PS ratio of 1.5x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 6.1% per year over the last three years.
- Revenues for these companies have grown 8.5% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Malaysian Healthcare industry?
| MY Market | -0.98% | |
| Healthcare | -1.02% | |
| Pharma | -2.13% | |
| Pharma | -2.13% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PLABS PeterLabs Holdings Berhad | RM 0.20 | 11.1% +RM 5.5m | -4.8% | PE18.9x |